CareDx
CDNA
63.04
-0.75
-1.18%
CareDx
US · CDNA
#2371 by market cap
Listed 1970
63.04
-0.75
-1.18%
Live - 5344 symbols - heartbeat 355s ago
· 2026-10-08 07:38
Pre-market
62.64
-0.63%
After-hours
63.00
-0.06%
Overnight
63.00
-0.06%
- Market cap
- 3.26B
- P/E (TTM)i
- 30.31
- P/Bi
- 7.66
- EPSi
- -0.40
- Div yieldi
- 0.00%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on CDNA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 16.48, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.79% YoY
Margins
- Gross margin
- 67.55%
- Operating margin
- -6.60%
- Net margin
- -5.62%
Key ratios & quality
- Altman Z-Scorei
- 16.48
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 76.57M | 127.07M | 192.19M | 296.40M | 321.79M | 280.32M | 333.79M | 379.81M |
| Gross profit | 43.58M | 81.61M | 129.08M | 199.01M | 209.58M | 178.26M | 224.09M | 256.57M |
| Selling & admin expenses | 44.65M | 75.43M | 102.66M | 152.21M | 196.42M | 202.90M | 207.11M | 210.21M |
| Research & development | 14.51M | 30.71M | 48.94M | 76.53M | 90.39M | 82.42M | 72.51M | 71.43M |
| Operating profit | -15.58M | -24.53M | -17.72M | -29.73M | -77.23M | -107.06M | -55.54M | -25.07M |
| Pretax profit | -48.22M | -23.95M | -19.75M | -32.09M | -76.23M | -190.14M | 52.86M | -21.08M |
| Tax | -1.43M | -1.98M | -1.04M | -1.43M | 379.00K | 141.00K | 310.00K | 271.00K |
| Net profit | -46.78M | -21.97M | -18.71M | -30.66M | -76.61M | -190.28M | 52.55M | -21.35M |
| Basic EPS | -1 | -1 | 0 | -1 | -1 | -4 | 1 | 0 |
| Diluted EPS | -1.31 | -0.52 | -0.40 | -0.59 | -1.44 | -3.54 | 0.93 | -0.40 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 84.69M | 86.68M | 100.06M | 108.39M | 117.70M | 131.95M |
| Gross profit | 56.27M | 58.02M | 69.40M | 72.87M | 84.07M | 96.98M |
| Selling & admin expenses | 45.76M | 51.96M | 52.88M | 59.61M | 60.86M | 74.35M |
| Research & development | 18.52M | 16.83M | 16.77M | 19.31M | 21.42M | 22.38M |
| Operating profit | -8.01M | -10.77M | -246.00K | -6.04M | 1.80M | 257.00K |
| Pretax profit | -10.30M | -8.69M | 1.66M | -3.76M | 2.78M | 114.52M |
| Tax | 58.00K | -117.00K | -15.00K | 345.00K | -32.00K | 3.88M |
| Net profit | -10.35M | -8.57M | 1.68M | -4.11M | 2.81M | 110.64M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 2 |
| Diluted EPS | -0.19 | -0.16 | 0.03 | -0.08 | 0.05 | 2.07 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 81.11M | 71.92M | 273.10M | 433.36M | 387.85M | 313.71M | 351.83M | 257.13M |
| Cash & ST investments | 64.62M | 38.22M | 224.70M | 348.49M | 293.09M | 235.42M | 260.65M | 177.21M |
| Inventory | 4.94M | 6.01M | 10.01M | 17.19M | 19.23M | 19.47M | 19.50M | 26.71M |
| Total assets | 130.70M | 151.74M | 368.51M | 566.62M | 542.99M | 466.83M | 491.05M | 413.23M |
| Total current liabilities | 19.50M | 34.83M | 69.22M | 77.30M | 75.98M | 78.07M | 89.37M | 89.85M |
| Short-term debt | -- | 3.02M | 2.03M | 3.96M | 5.59M | 5.94M | 6.10M | 6.52M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 34,769,000.00 | 52,736,000.00 | 90,832,000.00 | 100,745,000.00 | 112,080,000.00 | 205,498,000.00 | 112,617,000.00 | 110,127,000.00 |
| Total equity | 95.93M | 99.00M | 277.68M | 465.88M | 430.91M | 261.33M | 378.43M | 303.10M |
| Retained earnings | -311.85M | -333.81M | -352.53M | -383.19M | -460.44M | -678.27M | -626.24M | -735.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 350.24M | 307.30M | 300.28M | 257.13M | 269.40M | 429.22M |
| Cash & ST investments | 230.92M | 186.26M | 194.22M | 177.21M | 187.18M | 373.64M |
| Inventory | 22.93M | 27.92M | 28.33M | 26.71M | 26.40M | 6.98M |
| Total assets | 489.64M | 444.26M | 432.31M | 413.23M | 411.06M | 532.99M |
| Total current liabilities | 85.28M | 93.18M | 99.04M | 89.85M | 79.15M | 93.70M |
| Short-term debt | 6.21M | 6.34M | 6.43M | 6.52M | 6.66M | 6.05M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 110,289,000.00 | 116,887,000.00 | 121,167,000.00 | 110,127,000.00 | 97,527,000.00 | 107,390,000.00 |
| Total equity | 379.35M | 327.37M | 311.14M | 303.10M | 313.54M | 425.60M |
| Retained earnings | -636.60M | -695.16M | -719.05M | -735.36M | -732.55M | -505.45M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -4.01M | -2.77M | 33.43M | -19.29M | -25.24M | -18.39M | 38.05M | 42.03M |
| Depreciation & amortization | 4.22M | 7.14M | 9.54M | 11.89M | 16.01M | 19.82M | 19.76M | 20.42M |
| Free cash flow | -11.24M | -6.12M | 23.07M | -39.55M | -49.57M | -27.63M | 31.56M | 35.44M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 52.91M | 0 | 158.14M | 188.86M | -642.00K | -27.54M | -522.00K | -87.77M |
| Ending cash balance | 64.81M | 38.48M | 134.94M | 348.70M | 90.44M | 82.78M | 115.27M | 65.98M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -26.58M | 9.90M | 37.36M | 21.36M | 4.33M | 30.60M |
| Depreciation & amortization | 4.94M | 5.05M | 5.16M | 5.26M | 5.32M | 4.05M |
| Free cash flow | -28.21M | 8.89M | 35.38M | 19.39M | 514.00K | 28.75M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -25.56M | -12.21M | -- | -- |
| Ending cash balance | 89.30M | 68.76M | 91.99M | 65.98M | 78.47M | 374.16M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -104.14 | -22.54 | -9.94 | -8.25 | -17.09 | -54.98 | 16.43 | -6.27 |
| ROA %i | -43.64 | -15.56 | -7.19 | -6.56 | -13.81 | -37.69 | 10.97 | -4.72 |
| ROIC %i | -88.47 | -22.18 | -9.04 | -7.87 | -16.59 | -52.02 | 11.63 | -7.66 |
| 5-year avg ROE %i | -- | -231.54 | -225.78 | -195.20 | -32.39 | -22.56 | -14.76 | -14.03 |
| EBIT margin %i | -19.02 | -19.31 | -9.22 | -10.03 | -24.00 | -37.37 | -16.10 | -6.60 |
| FCF / sales %i | -- | -- | 12.00 | -- | -- | -- | 9.46 | 9.33 |
| Current ratioi | 4.16 | 2.07 | 3.95 | 5.61 | 5.10 | 4.02 | 3.94 | 2.86 |
| Quick ratioi | 3.81 | 1.79 | 3.75 | 5.28 | 4.73 | 3.67 | 3.64 | 2.45 |
| Debt / assetsi | 0.00 | 3.55 | 4.91 | 3.77 | 7.18 | 7.33 | 5.78 | 6.34 |
| LT debt / equityi | -- | 2.39 | 5.79 | 3.73 | 7.75 | 10.82 | 5.88 | 6.49 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 39.60 | 46.24 | 58.44 | 57.01 | 36.31 | 13.41 | 4.04 | 5.68 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.54 | 19.64 | 24.11 | -6.27 | -2.36 | 29.49 |
| ROA %i | 13.18 | 12.76 | 15.50 | -4.72 | -1.82 | 22.72 |
| ROIC %i | 14.45 | 14.40 | 18.77 | -7.66 | -3.52 | 25.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -11.32 | -12.51 | -8.15 | -6.60 | -3.70 | -0.92 |
| FCF / sales %i | 5.82 | 3.49 | 10.17 | 9.33 | 15.54 | 18.34 |
| Current ratioi | 4.11 | 3.30 | 3.03 | 2.86 | 3.40 | 4.58 |
| Quick ratioi | 3.55 | 2.72 | 2.44 | 2.45 | 2.93 | 4.35 |
| Debt / assetsi | 6.18 | 6.56 | 6.39 | 6.34 | 5.96 | 3.61 |
| LT debt / equityi | 6.35 | 6.96 | 6.82 | 6.49 | 5.69 | 3.10 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:38:07 · For reference only, not investment advice and not tailored to your situation.